Gynecologic & Ovarian Cancer Awareness – Her Health Hub
September. Gynecologic & Ovarian Cancer Awareness Month

Bloating Is Not Always Just Bloating.

Five cancers fall under the gynecologic umbrella. One of them, ovarian cancer, has no screening test and a survival rate that depends almost entirely on how early it is caught. Here is what the symptoms actually look like, who gets hit hardest, and what to say at your next appointment.

Teal Ribbon. National Ovarian Cancer Coalition's Wear Teal Day is Friday, September 4, 2026
110,850
women diagnosed with a gynecologic cancer in the U.S. every year (National Cancer Institute)
80%
of ovarian cancer cases are found at an advanced stage, after it has already spread
Zero
reliable screening tests exist for ovarian cancer. Pap smears do not detect it
92% vs 29%
five-year survival when caught localized, versus once it has spread to distant sites
The Five Cancers
Gynecologic cancer is not one disease. It is five, each with its own symptoms and its own risk. Cervical cancer is the only one of the five with a proven screening test. The other four are caught almost entirely by someone noticing a symptom and refusing to ignore it.

Cervical

Abnormal bleeding or discharge, pain during sex. The only gynecologic cancer with a proven screening test.

Pap test + HPV vaccine catch this early

Ovarian

Bloating, pelvic pain, feeling full quickly, urinary urgency. Vague enough to be dismissed for months.

No screening test exists

Uterine (Endometrial)

Abnormal bleeding, including any bleeding after menopause. Usually shows up earlier than ovarian cancer.

Most common gynecologic cancer overall

Vaginal

Unusual discharge or bleeding, a lump, pain during urination. Rare, and often mistaken for infection.

Vulvar

Persistent itching, skin color changes, or a lump on the vulva that does not resolve on its own.

The One With No Warning System
Ovarian Cancer

Researchers call it "the whispering disease" because it never shouts.

Ovarian cancer's symptoms, bloating, pelvic pressure, feeling full after a few bites, needing to urinate more often, mimic a bad week more than a diagnosis. Roughly 95% of women who are eventually diagnosed had these exact symptoms first. Almost none of them got checked in time.

There is a real, doctor-recognized threshold for when these symptoms stop being normal: new to you, happening more than 12 times a month, or lasting longer than two weeks. That is not a guess. It is the clinical bar gynecologic oncologists use to separate a rough week from a reason to test.

Why the odds shift so fast
92%
5-yr survival, localized stage
73%
5-yr survival, regional spread
29%
5-yr survival, distant spread

Only about 20% of ovarian cancer is caught while still localized. The other 80% is found after it has already moved past the ovary, which is where that survival number drops hardest.

Why there is no early test

CA-125 blood tests and transvaginal ultrasounds exist, but no major medical society recommends them as routine screening for average-risk women. Both produce enough false positives in low-risk populations that they lead to unnecessary surgeries without reliably catching more cancer earlier. Pap smears screen for cervical cancer only and have never screened for ovarian cancer, a myth that persists in a lot of doctor's offices.

Who should be screened anyway

Women with a BRCA1 or BRCA2 mutation carry a lifetime ovarian cancer risk between 11% and 62%, compared with about 1.3% for the general population. Lynch syndrome carries similar elevated risk. If ovarian, breast, uterine, or colorectal cancer runs in your family on either side, genetic counseling is the move, not a wait-and-see approach. For confirmed high-risk carriers, NCCN guidelines recommend TVUS and CA-125 testing every six months starting at age 30.

Sources: OCRA, National Cancer Institute, NCCN, Medscape.

The Disparity

Black women are diagnosed less and die more.

This is not a small gap. Across gynecologic cancers, Black women consistently present with more advanced disease and lower survival, even in studies that control for stage, insurance, and access to care.

Ovarian cancer
41%
5-yr survival, Black women
49%
5-yr survival, white women

A SEER data analysis found 41% of Black women present with stage IV disease at diagnosis, compared with 34% of white women. But stage does not fully explain the gap. A Cook County study of 47 hospitals found Black patients had worse survival than white patients with no significant difference in stage at diagnosis, and after adjusting for other factors, Black women remained 2.2 times more likely to die of ovarian cancer than white women.

Uterine (endometrial) cancer
2x
mortality rate, Black women
21%
lower 5-yr survival, Black women

Black women are diagnosed with uterine cancer less often than white women, and still nearly twice as likely to die from it. Part of this is biological: Black women are diagnosed with aggressive, non-endometrioid subtypes at higher rates. Part of it is not: researchers point to lower rates of guideline-recommended surgery and treatment, and disparities in how symptoms get taken seriously in the exam room.

Sources: SEER/National Cancer Institute, JAMA Oncology (2022), British Journal of Cancer (2023), Memorial Sloan Kettering.

Myths, Debunked
Myth
A Pap smear checks for ovarian cancer too.
Fact
A Pap smear only screens for cervical cancer. There has never been an equivalent screening test for ovarian cancer.
Myth
If my CA-125 comes back normal, I don't have ovarian cancer.
Fact
CA-125 can read normal even in confirmed early-stage disease. It's used to evaluate existing symptoms alongside imaging, not to rule cancer out on its own.
Myth
Ovarian cancer only happens to older women.
Fact
The median age at diagnosis is 63, which means half of women diagnosed are younger than that. It's rare under 40, not impossible, especially with a BRCA mutation.
Myth
No family history of cancer means I'm not high risk.
Fact
BRCA mutations pass through fathers just as often as mothers, and paternal-side cancer history rarely gets tracked the same way. A quiet family tree isn't proof of low risk.
Myth
Removing your ovaries removes all future risk.
Fact
Primary peritoneal cancer arises from the same cell lineage as ovarian cancer and can still develop after the ovaries are removed. Risk drops. It doesn't hit zero.
Myth
Bloating that comes and goes isn't worth mentioning to a doctor.
Fact
The clinical threshold isn't constant bloating. It's bloating that's new for you, happens more than 12 times a month, or lasts more than two weeks. That's worth a conversation every time.
What Actually Moves The Needle
  • Track bloating, pelvic pain, appetite changes, and urinary frequency for two weeks. Write down the date, how often, and how long each one lasts.
  • Use the actual clinical language with your doctor: "This is new for me, it's happening more than 12 times a month, and it's lasted more than two weeks."
  • Ask directly whether a pelvic exam, transvaginal ultrasound, or CA-125 test is warranted. Do not assume your annual pap smear already covers this.
  • Any bleeding after menopause, or bleeding between periods that is new for you, gets evaluated immediately. This is the earliest and clearest warning sign for uterine cancer.
  • If ovarian, breast, uterine, or colorectal cancer runs in your family, ask for a referral to genetic counseling for BRCA1, BRCA2, or Lynch syndrome testing.
  • If a provider attributes your symptoms to stress, IBS, or normal aging and nothing improves after treatment, request a referral to a gynecologic oncologist. That specialty exists for exactly this reason.
  • Bring your written symptom log to the appointment. A rushed 12-minute visit is not the place to rely on memory.
Where To Go From Here
Official Foundation

Foundation for Women's Cancer

The official foundation of the Society of Gynecologic Oncology. Covers all five gynecologic cancers, symptoms, and clinical trial access.

↗ foundationforwomenscancer.org
Largest Ovarian Cancer Nonprofit

Ovarian Cancer Research Alliance (OCRA)

Research funding, patient support, and the statistics cited throughout this page. Absorbed the Clearity Foundation and Rivkin Center in 2025.

↗ ocrahope.org
Smaller, Focused On Early Detection

Tina's Wish

Founded in 2008 in memory of Judge Tina Brozman. Funds research specifically aimed at finding an early detection test, since none exists yet.

↗ tinaswish.org
Smaller, Peer Support

SHARE Cancer Support

Volunteer-run since 1976 by breast and ovarian cancer survivors. Hotlines and support groups available in English, Spanish, and ten other languages.

↗ sharecancersupport.org
Government Resource

CDC: Gynecologic Cancers

Plain-language federal resource covering symptoms by cancer type, HPV vaccination guidance, and screening recommendations.

↗ cdc.gov/gynecologic-cancer
Wear Teal Day, Sept 4 2026

National Ovarian Cancer Coalition

Organizes Wear Teal Day and community-level awareness events. A direct line to local support and screening drives.

↗ ovarian.org
This content is for awareness and informational purposes only. It is not medical advice. Please consult a qualified healthcare provider for diagnosis, screening, and treatment decisions.
Her Health Hub The Kharis Company. The Language of Grace.